Concepedia

David Smil

DS

41

Publications

2.7K

Citations

28

H-Index

1999

Active since

Affiliations

University of Toronto(Current)

Structural Genomics Consortium

Princess Margaret Cancer Centre

Ontario Institute for Cancer Research

Icahn School of Medicine at Mount Sinai

David Smil is an author at University of Toronto specializing in medicine, natural sciences, and drug discovery.

Top concepts

MedicineNatural SciencesBiochemistryDrug DiscoveryPharmacologyMedicinal ChemistryChemical BiologyMolecular BiologyOrganic ChemistryChemistry

Publications per year

1999–2021

41

Publications

41

Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

Florian Grebien, Masoud Vedadi, Matthäus Getlik et al. · Nature Chemical Biology · 2015 · 282 citations · Full text

Hematological Malignancy, Medicine, Pharmacology +4

Potassium Alkenyl- and Aryltrifluoroborates: Stable and Efficient Agents for Rhodium-Catalyzed Addition to Aldehydes and Enones

Robert A. Batey, Avinash N. Thadani, David Smil · Organic Letters · 1999 · 187 citations

Chemical Engineering, Cross-coupling Reaction, Engineering +14

Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5

Guillermo Senisterra, Hong Wu, Abdellah Allali‐Hassani et al. · Biochemical Journal · 2012 · 158 citations · Full text

A chemical biology toolbox to study protein methyltransferases and epigenetic signaling

Sebastian Scheer, Suzanne Ackloo, Tiago da Silva Medina et al. · Nature Communications · 2018 · 147 citations · Full text

A Potent, Selective and Cell‐Active Allosteric Inhibitor of Protein Arginine Methyltransferase 3 (PRMT3)

H. Ümit Kanıskan, Magdalena M. Szewczyk, Zhengtian Yu et al. · Angewandte Chemie International Edition · 2015 · 126 citations · Full text

Rows per page

1–5 of 41